BR112021016879A2 - Composição para prevenção, melhora ou tratamento de obesidade ou doença hepática gordurosa compreendendo leuconostoc citreum wikim0104 - Google Patents

Composição para prevenção, melhora ou tratamento de obesidade ou doença hepática gordurosa compreendendo leuconostoc citreum wikim0104

Info

Publication number
BR112021016879A2
BR112021016879A2 BR112021016879A BR112021016879A BR112021016879A2 BR 112021016879 A2 BR112021016879 A2 BR 112021016879A2 BR 112021016879 A BR112021016879 A BR 112021016879A BR 112021016879 A BR112021016879 A BR 112021016879A BR 112021016879 A2 BR112021016879 A2 BR 112021016879A2
Authority
BR
Brazil
Prior art keywords
wikim0104
liver disease
leuconostoc citreum
fatty liver
composition
Prior art date
Application number
BR112021016879A
Other languages
English (en)
Inventor
CHOI Hak-Jong
LIM Seul-Ki
Original Assignee
Korea Food Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Korea Food Res Inst filed Critical Korea Food Res Inst
Publication of BR112021016879A2 publication Critical patent/BR112021016879A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/50—Feeding-stuffs specially adapted for particular animals for rodents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/332—Promoters of weight control and weight loss
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/31—Leuconostoc
    • A23V2400/315—Citreum
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Polymers & Plastics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Nutrition Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physiology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Birds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

composição para prevenção, melhora ou tratamento de obesidade ou doença hepática gordurosa compreendendo leuconostoc citreum wikim0104. refere-se a uma nova cepa leuconostoc citreum wikim0104 isolada de kimchi e a uma composição compreendendo a mesma ou seu uso. a presente invenção apresenta um método para prevenção, melhora e tratamento de inflamação, obesidade ou doença hepática gordurosa de um indivíduo, por meio da administração da nova cepa leuconostoc citreum wikim0104 isolada de kimchi ou uma composição contendo a mesma. a leuconostoc citreum wikim0104, de acordo com a presente invenção, mostra um efeito inibitório para a produção de esteatose hepática ao inibir o acúmulo de gordura nas células hepáticas e reduzir a expressão de genes relacionados à esteatose hepática e, portanto, pode ser utilizada de várias maneiras para usos na prevenção, na melhora e no tratamento de inflamação, obesidade ou doença hepática gordurosa.
BR112021016879A 2019-02-28 2020-02-27 Composição para prevenção, melhora ou tratamento de obesidade ou doença hepática gordurosa compreendendo leuconostoc citreum wikim0104 BR112021016879A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020190024254A KR102032982B1 (ko) 2019-02-28 2019-02-28 류코노스톡 시트래움 WiKim0104를 포함하는 비만 또는 지방간 질환의 예방, 개선 또는 치료용 조성물
PCT/KR2020/002845 WO2020175940A1 (ko) 2019-02-28 2020-02-27 류코노스톡 시트래움 wikim0104를 포함하는 비만 또는 지방간 질환의 예방, 개선 또는 치료용 조성물

Publications (1)

Publication Number Publication Date
BR112021016879A2 true BR112021016879A2 (pt) 2021-11-03

Family

ID=68421541

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112021016879A BR112021016879A2 (pt) 2019-02-28 2020-02-27 Composição para prevenção, melhora ou tratamento de obesidade ou doença hepática gordurosa compreendendo leuconostoc citreum wikim0104

Country Status (10)

Country Link
US (1) US20220047652A1 (pt)
EP (1) EP3933031A4 (pt)
JP (1) JP7201837B2 (pt)
KR (1) KR102032982B1 (pt)
CN (1) CN113498433B (pt)
AU (1) AU2020228247A1 (pt)
BR (1) BR112021016879A2 (pt)
CA (1) CA3131258A1 (pt)
MX (1) MX2021010350A (pt)
WO (1) WO2020175940A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102032982B1 (ko) * 2019-02-28 2019-10-16 한국식품연구원 류코노스톡 시트래움 WiKim0104를 포함하는 비만 또는 지방간 질환의 예방, 개선 또는 치료용 조성물
WO2022139531A1 (ko) * 2020-12-23 2022-06-30 주식회사 리스큐어바이오사이언시스 류코노스톡 시트리움 유래 세포밖 소포체를 유효성분으로 포함하는 지방간 개선, 예방 또는 치료용 조성물
KR20220091428A (ko) 2020-12-23 2022-06-30 주식회사 리스큐어바이오사이언시스 류코노스톡 시트리움 유래 세포밖 소포체를 유효성분으로 포함하는 지방간 개선, 예방 또는 치료용 조성물
WO2022169337A1 (ko) * 2021-02-08 2022-08-11 주식회사 리스큐어바이오사이언시스 류코노스톡 시트래움 균주를 유효성분으로 포함하는 장 손상의 예방 또는 치료용 약학 조성물
CA3207792A1 (en) * 2021-02-08 2022-08-11 Hwa Sup Chin Pharmaceutical composition for preventing or treating cholestatic liver injury comprising leuconostoc citreum strain as active ingredient
EP4289439A2 (en) * 2021-02-08 2023-12-13 Liscure Biosciences Co., Ltd. Pharmaceutical composition for prevention or treatment of fibrosis comprising leuconostoc citreum strain as active ingredient
KR102390715B1 (ko) * 2021-07-13 2022-04-29 한국식품연구원 류코노스톡 시트리움 WiKim0129를 포함하는 암의 예방, 개선 또는 치료용 조성물
CN115380998B (zh) * 2022-05-17 2023-07-07 西北工业大学 可获得改善人肝纤维化天然功能羊奶的奶山羊全混合日粮

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100872911B1 (ko) * 2007-10-25 2008-12-10 두두원발효(주) 김치유산균으로 발효한 콩 요구르트를 유효성분으로함유하는 비만억제용 조성물
KR20100037310A (ko) * 2008-10-01 2010-04-09 주식회사 비티엠 김치 유산균을 이용한 액상 건강보조식품의 제조방법
JP5801802B2 (ja) * 2010-06-08 2015-10-28 カルピス株式会社 脂質代謝改善剤
KR101704126B1 (ko) * 2014-06-12 2017-02-07 동국대학교 경주캠퍼스 산학협력단 아스퍼질러스 우사미 및 류코노스톡 시트륨 균주를 이용한 진세노사이드 함량이 증가된 홍삼 제제 및 이의 제조방법
KR20160108645A (ko) * 2015-03-04 2016-09-20 을지대학교 산학협력단 발효 두유 쏘이프로 상층액의 항염 효과 기능성 조성물 및 그 제조 방법
KR20170000510A (ko) * 2015-06-24 2017-01-03 주식회사 대유위니아 항비만 유산균의 발생을 위한 김치의 숙성방법 및 이것이 프로그래밍된 냉장고
KR20170032815A (ko) 2015-09-15 2017-03-23 경희대학교 산학협력단 신규 유산균 및 퇴행성 뇌질환 또는 인지기능의 예방, 개선 또는 치료용 조성물
KR101838280B1 (ko) * 2017-05-30 2018-03-14 한국식품연구원 관절염의 개선 활성을 갖는 류코노스톡 시트리움 wikim56 및 이를 포함하는 조성물
KR102390405B1 (ko) 2017-08-31 2022-04-25 한화테크윈 주식회사 도어벨 장치
KR102032982B1 (ko) * 2019-02-28 2019-10-16 한국식품연구원 류코노스톡 시트래움 WiKim0104를 포함하는 비만 또는 지방간 질환의 예방, 개선 또는 치료용 조성물

Also Published As

Publication number Publication date
WO2020175940A1 (ko) 2020-09-03
US20220047652A1 (en) 2022-02-17
EP3933031A4 (en) 2023-02-15
CA3131258A1 (en) 2020-09-03
AU2020228247A1 (en) 2021-09-30
EP3933031A1 (en) 2022-01-05
MX2021010350A (es) 2022-01-06
KR102032982B1 (ko) 2019-10-16
CN113498433B (zh) 2024-04-05
JP7201837B2 (ja) 2023-01-10
JP2022522300A (ja) 2022-04-15
CN113498433A (zh) 2021-10-12

Similar Documents

Publication Publication Date Title
BR112021016879A2 (pt) Composição para prevenção, melhora ou tratamento de obesidade ou doença hepática gordurosa compreendendo leuconostoc citreum wikim0104
BR112021016865A2 (pt) Composição para prevenção, melhora ou tratamento de obesidade ou doença hepática gordurosa compreendendo weissella hellenica wikim0103
CL2021002099A1 (es) Combinación farmacéutica que comprende tno155 y ribociclib.
PH12018501969A1 (en) Pharmaceutical composition comprising empagliflozin and uses thereof
ECSP21027262A (es) Agentes de ARNi para inhibir la expresión de 17beta-HSD tipo 13 (HSD17B13), composiciones de dichos agentes, y métodos de uso
ECSP21075909A (es) Inhibidores de la proteína tirosina fosfatasa y métodos para usarlos
BR112017026739A2 (pt) compostos para uso no tratamento de distúrbios neuromusculares
BR112016029781A2 (pt) composições e métodos para inibir a expressão de gene de alfa-1 antitripsina
BR112016018085A8 (pt) composições sinérgicas de suplemento dietético para prevenção, tratamento ou controle de doenças inflamatórias e respectivo método de aplicação das composições sinérgicas
BR112021019262A2 (pt) Uso de ciclo-his-pro (chp) para prevenir, atenuar ou tratar fibrose
BR112016026560A2 (pt) Método para tratar uma complicação de uma doença hepática crônica, método para tratar hipertensão portal, método para inibir uma cascata de sinalização de tnf-a e de a-fas; composição farmacêutica, kit, método de tratamento, método para tratar uma afecção
AR092993A1 (es) Laquinimod para reducir el daño talamico en la esclerosis multiple
Manaharan et al. Antimetastatic and anti‐inflammatory potentials of essential oil from edible Ocimum sanctum leaves
Valerio et al. β-Sitosterol modulates TLR4 receptor expression and intracellular MyD88-dependent pathway activation in J774A. 1 murine macrophages
Handayani et al. Brazilein in combination with cisplatin inhibit proliferation and migration on highly metastatic cancer cells, 4T1
BR112018008839A2 (pt) métodos e composições para o tratamento da amiloidose
BR112017018882A2 (pt) composição para aperfeiçoamento ou prevenção de uma doença de fígado gorduroso não alcoólico
BR112017007066A2 (pt) composições e métodos para melhorar a mobilidade ou a atividade, ou tratar a debilidade
BR112017024065A2 (pt) método para tratar insuficiência cardíaca avançada em um indivíduo humano
BR112019024082A2 (pt) Métodos de tratamento para distonia cervical
BR112023019984A2 (pt) Composição para prevenir ou tratar doenças neurodegenerativas compreendendo compostos que induzem a expressão do gene antienvelhecimento klotho
BR112018011552A2 (pt) métodos e composições para tratamento de úlceras gástricas
BR112017002911A2 (pt) composição para prevenção ou tratamento de obesidade contendo ácido alfa-lipóico e n-acetilcisteína como ingredientes ativos
BR112021024165A2 (pt) Composições e métodos para o tratamento de doenças metabólicas
WO2016178490A3 (ko) 곰보배추 추출물 또는 이의 분획물을 포함하는 통풍 예방 또는 치료용 약학적 조성물 및 고요산혈증 개선용 식품 조성물